Secondary mutations in the kinase domain of the <i> KIT</i> gene are predominant in imatinib‐resistant gastrointestinal stromal tumorToshirou Nishida, Seiichi Hirota|Cancer Science|2008Cited by 111
Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activationNami Nakagomi, Seiichi Hirota|Laboratory Investigation|2007Cited by 65
Different inhibitory effect of imatinib on phosphorylation of mitogen‐activated protein kinase and Akt and on proliferation in cells expressing different types of mutant platelet‐derived growth factor receptor‐αAkiko Ohashi, Seiichi Hirota|International Journal of Cancer|2004Cited by 17
Epithelioid glioblastoma with microglia features: potential for novel therapyNami Nakagomi, Seiichi Hirota|Brain Pathology|2020Cited by 13
In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in miceTakashi Ishikawa, Seiichi Hirota|Laboratory Investigation|2009Cited by 9